Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/23501
Title: Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.
Authors: 
Mesh: 
Issue Date: 1-Jan-2015
Citation: J. Clin. Oncol..2015 Jan;(33)1:22-8
Abstract: Progression-free survival (PFS) has previously been established as a surrogate for overall survival (OS) for first-line metastatic colorectal cancer (mCRC). Because mCRC treatment has advanced in the last decade with extended OS, this surrogacy requires re-examination.
PMID: 25385741
URI: https://hdl.handle.net/20.500.12530/23501
Rights: openAccess
Appears in Collections:Hospitales > H. U. Clínico San Carlos > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC4482837.pdf180.82 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.